<DOC>
	<DOCNO>NCT00632814</DOCNO>
	<brief_summary>A prospective study evaluate effect rFVIII-FS different prophylactic regimen bleed event frequency development arthropathy Previously Treated Minimally treat Hemophilia A pediatric population .</brief_summary>
	<brief_title>Russian Kogenate Pediatric Study</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Male Severe hemophilia A moderate hemophilia A 112 year age Requiring treatment FVIII Current prior inhibitor familial antecedent inhibitor Surgery require study ( 9 month ) Positive HIV</criteria>
	<gender>Male</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Kogenate ,</keyword>
	<keyword>Children ,</keyword>
	<keyword>Factor VIII ,</keyword>
	<keyword>Hemophilia A ,</keyword>
	<keyword>Prophylactic</keyword>
</DOC>